Perry v. Novartis Pharmaceuticals Corporation
Public Justice opposed the drug company Novartis’s federal preemption defense in this case involving the prescription drug Elidel. In its motion to dismiss, Novartis argued that the plaintiffs’ failure-to-warn claims were preempted because they conflicted with the U.S. Food and Drug Administration’s approval of the…